Search

Your search keyword '"Rodrigues CIS"' showing total 39 results
Start Over Author "Rodrigues CIS"
39 results on '"Rodrigues CIS"'

2. 6ª Diretrizes de Monitorização Ambulatorial da Pressão Arterial e 4ª Diretrizes de Monitorização Residencial da Pressão Arterial

Author

Nobre, F, primary, Mion Júnior, D, additional, Gomes, MAM, additional, Barbosa, ECD, additional, Rodrigues, CIS, additional, Neves, MFT, additional, Brandão, AA, additional, Alessi, AA, additional, Feitosa, AM, additional, Machado, CA, additional, Poli-de-Figueiredo, CE, additional, Amodeo, C, additional, Forjaz, CLM, additional, Giorgi, DMA, additional, Coelho, EB, additional, Lima Jr., E, additional, Plavnik, FL, additional, Silva, GV, additional, Chaves Jr., H, additional, Vilela-Martin, JFV, additional, Ribeiro, JM, additional, Gusmão, JL, additional, Yugar-Toledo, JC, additional, Bortolotto, LA, additional, Scala, LCN, additional, Malachias, MVB, additional, Wajngarten, M, additional, Gus, M, additional, Passarelli Jr., O, additional, Jardim, PCBV, additional, Miranda, RD, additional, Paula, RB, additional, Ferreira-Filho, SR, additional, Andrade, S, additional, Geleilete, TJM, additional, Koch, VHK, additional, Souza, WKSB, additional, and Oigman, W, additional

Published
2018
Full Text
View/download PDF

3. Capítulo 3 - Avaliação Clínica e Complementar

Author

Malachias, MVB, primary, Souza, WKSB, additional, Plavnik, FL, additional, Rodrigues, CIS, additional, Brandão, AA, additional, Neves, MFT, additional, Bortolotto, LA, additional, Franco, RJS, additional, Figueiredo, CEP, additional, Jardim, PCBV, additional, Amodeo, C, additional, Barbosa, ECD, additional, Koch, V, additional, Gomes, MAM, additional, Paula, RB, additional, Póvoa, RMS, additional, Colombo, FC, additional, Ferreira Filho, S, additional, Miranda, RD, additional, Machado, CA, additional, Nobre, F, additional, Nogueira, AR, additional, Mion Júnior, D, additional, Kaiser, S, additional, Forjaz, CLM, additional, Almeida, FA, additional, Martim, JFV, additional, Sass, N, additional, Drager, LF, additional, Muxfeldt, E, additional, Bodanese, LC, additional, Feitosa, AD, additional, Malta, D, additional, Fuchs, S, additional, Magalhães, ME, additional, Oigman, W, additional, Gomes, OM, additional, Pierin, AMG, additional, Feitosa, GS, additional, Bortolotto, MRFL, additional, Magalhães, LBNC, additional, Silva, ACS, additional, Ribeiro, JM, additional, Borelli, FAO, additional, Gus, M, additional, Passarelli Júnior, O, additional, Toledo, JY, additional, Salles, GF, additional, Martins, LC, additional, Jardim, TSV, additional, Guimarães, ICB, additional, Antonello, IC, additional, Lima Júnior, E, additional, Matsudo, V, additional, Silva, GV, additional, Costa, LS, additional, Alessi, A, additional, Scala, LCN, additional, Coelho, EB, additional, Souza, D, additional, Lopes, HF, additional, Gowdak, MMG, additional, Cordeiro Júnior, AC, additional, Torloni, MR, additional, Klein, MRST, additional, Nogueira, PK, additional, Lotaif, LAD, additional, Rosito, GBA, additional, and Moreno Júnior, H, additional

Published
2016
Full Text
View/download PDF

4. Capítulo 12 - Hipertensão Arterial Secundária

Author

Malachias, MVB, primary, Souza, WKSB, additional, Plavnik, FL, additional, Rodrigues, CIS, additional, Brandão, AA, additional, Neves, MFT, additional, Bortolotto, LA, additional, Franco, RJS, additional, Figueiredo, CEP, additional, Jardim, PCBV, additional, Amodeo, C, additional, Barbosa, ECD, additional, Koch, V, additional, Gomes, MAM, additional, Paula, RB, additional, Póvoa, RMS, additional, Colombo, FC, additional, Ferreira Filho, S, additional, Miranda, RD, additional, Machado, CA, additional, Nobre, F, additional, Nogueira, AR, additional, Mion Júnior, D, additional, Kaiser, S, additional, Forjaz, CLM, additional, Almeida, FA, additional, Martim, JFV, additional, Sass, N, additional, Drager, LF, additional, Muxfeldt, E, additional, Bodanese, LC, additional, Feitosa, AD, additional, Malta, D, additional, Fuchs, S, additional, Magalhães, ME, additional, Oigman, W, additional, Gomes, OM, additional, Pierin, AMG, additional, Feitosa, GS, additional, Bortolotto, MRFL, additional, Magalhães, LBNC, additional, Silva, ACS, additional, Ribeiro, JM, additional, Borelli, FAO, additional, Gus, M, additional, Passarelli Júnior, O, additional, Toledo, JY, additional, Salles, GF, additional, Martins, LC, additional, Jardim, TSV, additional, Guimarães, ICB, additional, Antonello, IC, additional, Lima Júnior, E, additional, Matsudo, V, additional, Silva, GV, additional, Costa, LS, additional, Alessi, A, additional, Scala, LCN, additional, Coelho, EB, additional, Souza, D, additional, Lopes, HF, additional, Gowdak, MMG, additional, Cordeiro Júnior, AC, additional, Torloni, MR, additional, Klein, MRST, additional, Nogueira, PK, additional, Lotaif, LAD, additional, Rosito, GBA, additional, and Moreno Júnior, H, additional

Published
2016
Full Text
View/download PDF

5. Capítulo 4 - Estratificaçã o de Risco Cardiovascular

Author

Malachias, MVB, primary, Souza, WKSB, additional, Plavnik, FL, additional, Rodrigues, CIS, additional, Brandão, AA, additional, Neves, MFT, additional, Bortolotto, LA, additional, Franco, RJS, additional, Figueiredo, CEP, additional, Jardim, PCBV, additional, Amodeo, C, additional, Barbosa, ECD, additional, Koch, V, additional, Gomes, MAM, additional, Paula, RB, additional, Póvoa, RMS, additional, Colombo, FC, additional, Ferreira Filho, S, additional, Miranda, RD, additional, Machado, CA, additional, Nobre, F, additional, Nogueira, AR, additional, Mion Júnior, D, additional, Kaiser, S, additional, Forjaz, CLM, additional, Almeida, FA, additional, Martim, JFV, additional, Sass, N, additional, Drager, LF, additional, Muxfeldt, E, additional, Bodanese, LC, additional, Feitosa, AD, additional, Malta, D, additional, Fuchs, S, additional, Magalhães, ME, additional, Oigman, W, additional, Gomes, OM, additional, Pierin, AMG, additional, Feitosa, GS, additional, Bortolotto, MRFL, additional, Magalhães, LBNC, additional, Silva, ACS, additional, Ribeiro, JM, additional, Borelli, FAO, additional, Gus, M, additional, Passarelli Júnior, O, additional, Toledo, JY, additional, Salles, GF, additional, Martins, LC, additional, Jardim, TSV, additional, Guimarães, ICB, additional, Antonello, IC, additional, Lima Júnior, E, additional, Matsudo, V, additional, Silva, GV, additional, Costa, LS, additional, Alessi, A, additional, Scala, LCN, additional, Coelho, EB, additional, Souza, D, additional, Lopes, HF, additional, Gowdak, MMG, additional, Cordeiro Júnior, AC, additional, Torloni, MR, additional, Klein, MRST, additional, Nogueira, PK, additional, Lotaif, LAD, additional, Rosito, GBA, additional, and Moreno Júnior, H, additional

Published
2016
Full Text
View/download PDF

6. Capítulo 13 - Hipertensão Arterial Resistente

Author

Malachias, MVB, primary, Souza, WKSB, additional, Plavnik, FL, additional, Rodrigues, CIS, additional, Brandão, AA, additional, Neves, MFT, additional, Bortolotto, LA, additional, Franco, RJS, additional, Figueiredo, CEP, additional, Jardim, PCBV, additional, Amodeo, C, additional, Barbosa, ECD, additional, Koch, V, additional, Gomes, MAM, additional, Paula, RB, additional, Póvoa, RMS, additional, Colombo, FC, additional, Ferreira Filho, S, additional, Miranda, RD, additional, Machado, CA, additional, Nobre, F, additional, Nogueira, AR, additional, Mion Júnior, D, additional, Kaiser, S, additional, Forjaz, CLM, additional, Almeida, FA, additional, Martim, JFV, additional, Sass, N, additional, Drager, LF, additional, Muxfeldt, E, additional, Bodanese, LC, additional, Feitosa, AD, additional, Malta, D, additional, Fuchs, S, additional, Magalhães, ME, additional, Oigman, W, additional, Gomes, OM, additional, Pierin, AMG, additional, Feitosa, GS, additional, Bortolotto, MRFL, additional, Magalhães, LBNC, additional, Silva, ACS, additional, Ribeiro, JM, additional, Borelli, FAO, additional, Gus, M, additional, Passarelli Júnior, O, additional, Toledo, JY, additional, Salles, GF, additional, Martins, LC, additional, Jardim, TSV, additional, Guimarães, ICB, additional, Antonello, IC, additional, Lima Júnior, E, additional, Matsudo, V, additional, Silva, GV, additional, Costa, LS, additional, Alessi, A, additional, Scala, LCN, additional, Coelho, EB, additional, Souza, D, additional, Lopes, HF, additional, Gowdak, MMG, additional, Cordeiro Júnior, AC, additional, Torloni, MR, additional, Klein, MRST, additional, Nogueira, PK, additional, Lotaif, LAD, additional, Rosito, GBA, additional, and Moreno Júnior, H, additional

Published
2016
Full Text
View/download PDF

7. Capítulo 5 - Decisão e Metas Terapêuticas

Author

Malachias, MVB, primary, Souza, WKSB, additional, Plavnik, FL, additional, Rodrigues, CIS, additional, Brandão, AA, additional, Neves, MFT, additional, Bortolotto, LA, additional, Franco, RJS, additional, Figueiredo, CEP, additional, Jardim, PCBV, additional, Amodeo, C, additional, Barbosa, ECD, additional, Koch, V, additional, Gomes, MAM, additional, Paula, RB, additional, Póvoa, RMS, additional, Colombo, FC, additional, Ferreira Filho, S, additional, Miranda, RD, additional, Machado, CA, additional, Nobre, F, additional, Nogueira, AR, additional, Mion Júnior, D, additional, Kaiser, S, additional, Forjaz, CLM, additional, Almeida, FA, additional, Martim, JFV, additional, Sass, N, additional, Drager, LF, additional, Muxfeldt, E, additional, Bodanese, LC, additional, Feitosa, AD, additional, Malta, D, additional, Fuchs, S, additional, Magalhães, ME, additional, Oigman, W, additional, Gomes, OM, additional, Pierin, AMG, additional, Feitosa, GS, additional, Bortolotto, MRFL, additional, Magalhães, LBNC, additional, Silva, ACS, additional, Ribeiro, JM, additional, Borelli, FAO, additional, Gus, M, additional, Passarelli Júnior, O, additional, Toledo, JY, additional, Salles, GF, additional, Martins, LC, additional, Jardim, TSV, additional, Guimarães, ICB, additional, Antonello, IC, additional, Lima Júnior, E, additional, Matsudo, V, additional, Silva, GV, additional, Costa, LS, additional, Alessi, A, additional, Scala, LCN, additional, Coelho, EB, additional, Souza, D, additional, Lopes, HF, additional, Gowdak, MMG, additional, Cordeiro Júnior, AC, additional, Torloni, MR, additional, Klein, MRST, additional, Nogueira, PK, additional, Lotaif, LAD, additional, Rosito, GBA, additional, and Moreno Júnior, H, additional

Published
2016
Full Text
View/download PDF

8. Capítulo 1 - Conceituação, Epidemiologia e Prevenção Primária

Author

Malachias, MVB, primary, Souza, WKSB, additional, Plavnik, FL, additional, Rodrigues, CIS, additional, Brandão, AA, additional, Neves, MFT, additional, Bortolotto, LA, additional, Franco, RJS, additional, Figueiredo, CEP, additional, Jardim, PCBV, additional, Amodeo, C, additional, Barbosa, ECD, additional, Koch, V, additional, Gomes, MAM, additional, Paula, RB, additional, Póvoa, RMS, additional, Colombo, FC, additional, Ferreira Filho, S, additional, Miranda, RD, additional, Machado, CA, additional, Nobre, F, additional, Nogueira, AR, additional, Mion Júnior, D, additional, Kaiser, S, additional, Forjaz, CLM, additional, Almeida, FA, additional, Martim, JFV, additional, Sass, N, additional, Drager, LF, additional, Muxfeldt, E, additional, Bodanese, LC, additional, Feitosa, AD, additional, Malta, D, additional, Fuchs, S, additional, Magalhães, ME, additional, Oigman, W, additional, Gomes, OM, additional, Pierin, AMG, additional, Feitosa, GS, additional, Bortolotto, MRFL, additional, Magalhães, LBNC, additional, Silva, ACS, additional, Ribeiro, JM, additional, Borelli, FAO, additional, Gus, M, additional, Passarelli Júnior, O, additional, Toledo, JY, additional, Salles, GF, additional, Martins, LC, additional, Jardim, TSV, additional, Guimarães, ICB, additional, Antonello, IC, additional, Lima Júnior, E, additional, Matsudo, V, additional, Silva, GV, additional, Costa, LS, additional, Alessi, A, additional, Scala, LCN, additional, Coelho, EB, additional, Souza, D, additional, Lopes, HF, additional, Gowdak, MMG, additional, Cordeiro Júnior, AC, additional, Torloni, MR, additional, Klein, MRST, additional, Nogueira, PK, additional, Lotaif, LAD, additional, Rosito, GBA, additional, and Moreno Júnior, H, additional

Published
2016
Full Text
View/download PDF

9. Capítulo 10 - Hipertensão na Criança e no Adolescente

Author

Malachias, MVB, primary, Souza, WKSB, additional, Plavnik, FL, additional, Rodrigues, CIS, additional, Brandão, AA, additional, Neves, MFT, additional, Bortolotto, LA, additional, Franco, RJS, additional, Figueiredo, CEP, additional, Jardim, PCBV, additional, Amodeo, C, additional, Barbosa, ECD, additional, Koch, V, additional, Gomes, MAM, additional, Paula, RB, additional, Póvoa, RMS, additional, Colombo, FC, additional, Ferreira Filho, S, additional, Miranda, RD, additional, Machado, CA, additional, Nobre, F, additional, Nogueira, AR, additional, Mion Júnior, D, additional, Kaiser, S, additional, Forjaz, CLM, additional, Almeida, FA, additional, Martim, JFV, additional, Sass, N, additional, Drager, LF, additional, Muxfeldt, E, additional, Bodanese, LC, additional, Feitosa, AD, additional, Malta, D, additional, Fuchs, S, additional, Magalhães, ME, additional, Oigman, W, additional, Gomes, OM, additional, Pierin, AMG, additional, Feitosa, GS, additional, Bortolotto, MRFL, additional, Magalhães, LBNC, additional, Silva, ACS, additional, Ribeiro, JM, additional, Borelli, FAO, additional, Gus, M, additional, Passarelli Júnior, O, additional, Toledo, JY, additional, Salles, GF, additional, Martins, LC, additional, Jardim, TSV, additional, Guimarães, ICB, additional, Antonello, IC, additional, Lima Júnior, E, additional, Matsudo, V, additional, Silva, GV, additional, Costa, LS, additional, Alessi, A, additional, Scala, LCN, additional, Coelho, EB, additional, Souza, D, additional, Lopes, HF, additional, Gowdak, MMG, additional, Cordeiro Júnior, AC, additional, Torloni, MR, additional, Klein, MRST, additional, Nogueira, PK, additional, Lotaif, LAD, additional, Rosito, GBA, additional, and Moreno Júnior, H, additional

Published
2016
Full Text
View/download PDF

10. Capítulo 14 – Crise Hipertensiva

Author

Malachias, MVB, primary, Souza, WKSB, additional, Plavnik, FL, additional, Rodrigues, CIS, additional, Brandão, AA, additional, Neves, MFT, additional, Bortolotto, LA, additional, Franco, RJS, additional, Figueiredo, CEP, additional, Jardim, PCBV, additional, Amodeo, C, additional, Barbosa, ECD, additional, Koch, V, additional, Gomes, MAM, additional, Paula, RB, additional, Póvoa, RMS, additional, Colombo, FC, additional, Ferreira Filho, S, additional, Miranda, RD, additional, Machado, CA, additional, Nobre, F, additional, Nogueira, AR, additional, Mion Júnior, D, additional, Kaiser, S, additional, Forjaz, CLM, additional, Almeida, FA, additional, Martim, JFV, additional, Sass, N, additional, Drager, LF, additional, Muxfeldt, E, additional, Bodanese, LC, additional, Feitosa, AD, additional, Malta, D, additional, Fuchs, S, additional, Magalhães, ME, additional, Oigman, W, additional, Gomes, OM, additional, Pierin, AMG, additional, Feitosa, GS, additional, Bortolotto, MRFL, additional, Magalhães, LBNC, additional, Silva, ACS, additional, Ribeiro, JM, additional, Borelli, FAO, additional, Gus, M, additional, Passarelli Júnior, O, additional, Toledo, JY, additional, Salles, GF, additional, Martins, LC, additional, Jardim, TSV, additional, Guimarães, ICB, additional, Antonello, IC, additional, Lima Júnior, E, additional, Matsudo, V, additional, Silva, GV, additional, Costa, LS, additional, Alessi, A, additional, Scala, LCN, additional, Coelho, EB, additional, Souza, D, additional, Lopes, HF, additional, Gowdak, MMG, additional, Cordeiro Júnior, AC, additional, Torloni, MR, additional, Klein, MRST, additional, Nogueira, PK, additional, Lotaif, LAD, additional, Rosito, GBA, additional, and Moreno Júnior, H, additional

Published
2016
Full Text
View/download PDF

11. Capítulo 8 - Hipertensão e Condições Clínicas Associadas

Author

Malachias, MVB, primary, Souza, WKSB, additional, Plavnik, FL, additional, Rodrigues, CIS, additional, Brandão, AA, additional, Neves, MFT, additional, Bortolotto, LA, additional, Franco, RJS, additional, Figueiredo, CEP, additional, Jardim, PCBV, additional, Amodeo, C, additional, Barbosa, ECD, additional, Koch, V, additional, Gomes, MAM, additional, Paula, RB, additional, Póvoa, RMS, additional, Colombo, FC, additional, Ferreira Filho, S, additional, Miranda, RD, additional, Machado, CA, additional, Nobre, F, additional, Nogueira, AR, additional, Mion Júnior, D, additional, Kaiser, S, additional, Forjaz, CLM, additional, Almeida, FA, additional, Martim, JFV, additional, Sass, N, additional, Drager, LF, additional, Muxfeldt, E, additional, Bodanese, LC, additional, Feitosa, AD, additional, Malta, D, additional, Fuchs, S, additional, Magalhães, ME, additional, Oigman, W, additional, Gomes, OM, additional, Pierin, AMG, additional, Feitosa, GS, additional, Bortolotto, MRFL, additional, Magalhães, LBNC, additional, Silva, ACS, additional, Ribeiro, JM, additional, Borelli, FAO, additional, Gus, M, additional, Passarelli Júnior, O, additional, Toledo, JY, additional, Salles, GF, additional, Martins, LC, additional, Jardim, TSV, additional, Guimarães, ICB, additional, Antonello, IC, additional, Lima Júnior, E, additional, Matsudo, V, additional, Silva, GV, additional, Costa, LS, additional, Alessi, A, additional, Scala, LCN, additional, Coelho, EB, additional, Souza, D, additional, Lopes, HF, additional, Gowdak, MMG, additional, Cordeiro Júnior, AC, additional, Torloni, MR, additional, Klein, MRST, additional, Nogueira, PK, additional, Lotaif, LAD, additional, Rosito, GBA, additional, and Moreno Júnior, H, additional

Published
2016
Full Text
View/download PDF

12. Capítulo 11 - Hipertensão Arterial no Idoso

Author

Malachias, MVB, primary, Souza, WKSB, additional, Plavnik, FL, additional, Rodrigues, CIS, additional, Brandão, AA, additional, Neves, MFT, additional, Bortolotto, LA, additional, Franco, RJS, additional, Figueiredo, CEP, additional, Jardim, PCBV, additional, Amodeo, C, additional, Barbosa, ECD, additional, Koch, V, additional, Gomes, MAM, additional, Paula, RB, additional, Póvoa, RMS, additional, Colombo, FC, additional, Ferreira Filho, S, additional, Miranda, RD, additional, Machado, CA, additional, Nobre, F, additional, Nogueira, AR, additional, Mion Júnior, D, additional, Kaiser, S, additional, Forjaz, CLM, additional, Almeida, FA, additional, Martim, JFV, additional, Sass, N, additional, Drager, LF, additional, Muxfeldt, E, additional, Bodanese, LC, additional, Feitosa, AD, additional, Malta, D, additional, Fuchs, S, additional, Magalhães, ME, additional, Oigman, W, additional, Gomes, OM, additional, Pierin, AMG, additional, Feitosa, GS, additional, Bortolotto, MRFL, additional, Magalhães, LBNC, additional, Silva, ACS, additional, Ribeiro, JM, additional, Borelli, FAO, additional, Gus, M, additional, Passarelli Júnior, O, additional, Toledo, JY, additional, Salles, GF, additional, Martins, LC, additional, Jardim, TSV, additional, Guimarães, ICB, additional, Antonello, IC, additional, Lima Júnior, E, additional, Matsudo, V, additional, Silva, GV, additional, Costa, LS, additional, Alessi, A, additional, Scala, LCN, additional, Coelho, EB, additional, Souza, D, additional, Lopes, HF, additional, Gowdak, MMG, additional, Cordeiro Júnior, AC, additional, Torloni, MR, additional, Klein, MRST, additional, Nogueira, PK, additional, Lotaif, LAD, additional, Rosito, GBA, additional, and Moreno Júnior, H, additional

Published
2016
Full Text
View/download PDF

13. Capítulo 6 - Tratamento não medicamentoso

Author

Malachias, MVB, primary, Souza, WKSB, additional, Plavnik, FL, additional, Rodrigues, CIS, additional, Brandão, AA, additional, Neves, MFT, additional, Bortolotto, LA, additional, Franco, RJS, additional, Figueiredo, CEP, additional, Jardim, PCBV, additional, Amodeo, C, additional, Barbosa, ECD, additional, Koch, V, additional, Gomes, MAM, additional, Paula, RB, additional, Póvoa, RMS, additional, Colombo, FC, additional, Ferreira Filho, S, additional, Miranda, RD, additional, Machado, CA, additional, Nobre, F, additional, Nogueira, AR, additional, Mion Júnior, D, additional, Kaiser, S, additional, Forjaz, CLM, additional, Almeida, FA, additional, Martim, JFV, additional, Sass, N, additional, Drager, LF, additional, Muxfeldt, E, additional, Bodanese, LC, additional, Feitosa, AD, additional, Malta, D, additional, Fuchs, S, additional, Magalhães, ME, additional, Oigman, W, additional, Gomes, OM, additional, Pierin, AMG, additional, Feitosa, GS, additional, Bortolotto, MRFL, additional, Magalhães, LBNC, additional, Silva, ACS, additional, Ribeiro, JM, additional, Borelli, FAO, additional, Gus, M, additional, Passarelli Júnior, O, additional, Toledo, JY, additional, Salles, GF, additional, Martins, LC, additional, Jardim, TSV, additional, Guimarães, ICB, additional, Antonello, IC, additional, Lima Júnior, E, additional, Matsudo, V, additional, Silva, GV, additional, Costa, LS, additional, Alessi, A, additional, Scala, LCN, additional, Coelho, EB, additional, Souza, D, additional, Lopes, HF, additional, Gowdak, MMG, additional, Cordeiro Júnior, AC, additional, Torloni, MR, additional, Klein, MRST, additional, Nogueira, PK, additional, Lotaif, LAD, additional, Rosito, GBA, additional, and Moreno Júnior, H, additional

Published
2016
Full Text
View/download PDF

14. Capítulo 9 - Hipertensão Arterial na gestação

Author

Malachias, MVB, primary, Souza, WKSB, additional, Plavnik, FL, additional, Rodrigues, CIS, additional, Brandão, AA, additional, Neves, MFT, additional, Bortolotto, LA, additional, Franco, RJS, additional, Figueiredo, CEP, additional, Jardim, PCBV, additional, Amodeo, C, additional, Barbosa, ECD, additional, Koch, V, additional, Gomes, MAM, additional, Paula, RB, additional, Póvoa, RMS, additional, Colombo, FC, additional, Ferreira Filho, S, additional, Miranda, RD, additional, Machado, CA, additional, Nobre, F, additional, Nogueira, AR, additional, Mion Júnior, D, additional, Kaiser, S, additional, Forjaz, CLM, additional, Almeida, FA, additional, Martim, JFV, additional, Sass, N, additional, Drager, LF, additional, Muxfeldt, E, additional, Bodanese, LC, additional, Feitosa, AD, additional, Malta, D, additional, Fuchs, S, additional, Magalhães, ME, additional, Oigman, W, additional, Gomes, OM, additional, Pierin, AMG, additional, Feitosa, GS, additional, Bortolotto, MRFL, additional, Magalhães, LBNC, additional, Silva, ACS, additional, Ribeiro, JM, additional, Borelli, FAO, additional, Gus, M, additional, Passarelli Júnior, O, additional, Toledo, JY, additional, Salles, GF, additional, Martins, LC, additional, Jardim, TSV, additional, Guimarães, ICB, additional, Antonello, IC, additional, Lima Júnior, E, additional, Matsudo, V, additional, Silva, GV, additional, Costa, LS, additional, Alessi, A, additional, Scala, LCN, additional, Coelho, EB, additional, Souza, D, additional, Lopes, HF, additional, Gowdak, MMG, additional, Cordeiro Júnior, AC, additional, Torloni, MR, additional, Klein, MRST, additional, Nogueira, PK, additional, Lotaif, LAD, additional, Rosito, GBA, additional, and Moreno Júnior, H, additional

Published
2016
Full Text
View/download PDF

15. Capítulo 7 – Tratamento Medicamentoso

Author

Malachias, MVB, primary, Souza, WKSB, additional, Plavnik, FL, additional, Rodrigues, CIS, additional, Brandão, AA, additional, Neves, MFT, additional, Bortolotto, LA, additional, Franco, RJS, additional, Figueiredo, CEP, additional, Jardim, PCBV, additional, Amodeo, C, additional, Barbosa, ECD, additional, Koch, V, additional, Gomes, MAM, additional, Paula, RB, additional, Póvoa, RMS, additional, Colombo, FC, additional, Ferreira Filho, S, additional, Miranda, RD, additional, Machado, CA, additional, Nobre, F, additional, Nogueira, AR, additional, Mion Júnior, D, additional, Kaiser, S, additional, Forjaz, CLM, additional, Almeida, FA, additional, Martim, JFV, additional, Sass, N, additional, Drager, LF, additional, Muxfeldt, E, additional, Bodanese, LC, additional, Feitosa, AD, additional, Malta, D, additional, Fuchs, S, additional, Magalhães, ME, additional, Oigman, W, additional, Gomes, OM, additional, Pierin, AMG, additional, Feitosa, GS, additional, Bortolotto, MRFL, additional, Magalhães, LBNC, additional, Silva, ACS, additional, Ribeiro, JM, additional, Borelli, FAO, additional, Gus, M, additional, Passarelli Júnior, O, additional, Toledo, JY, additional, Salles, GF, additional, Martins, LC, additional, Jardim, TSV, additional, Guimarães, ICB, additional, Antonello, IC, additional, Lima Júnior, E, additional, Matsudo, V, additional, Silva, GV, additional, Costa, LS, additional, Alessi, A, additional, Scala, LCN, additional, Coelho, EB, additional, Souza, D, additional, Lopes, HF, additional, Gowdak, MMG, additional, Cordeiro Júnior, AC, additional, Torloni, MR, additional, Klein, MRST, additional, Nogueira, PK, additional, Lotaif, LAD, additional, Rosito, GBA, additional, and Moreno Júnior, H, additional

Published
2016
Full Text
View/download PDF

16. Capítulo 2 - Diagnóstico e Classificação

Author

Malachias, MVB, primary, Souza, WKSB, additional, Plavnik, FL, additional, Rodrigues, CIS, additional, Brandão, AA, additional, Neves, MFT, additional, Bortolotto, LA, additional, Franco, RJS, additional, Figueiredo, CEP, additional, Jardim, PCBV, additional, Amodeo, C, additional, Barbosa, ECD, additional, Koch, V, additional, Gomes, MAM, additional, Paula, RB, additional, Póvoa, RMS, additional, Colombo, FC, additional, Ferreira Filho, S, additional, Miranda, RD, additional, Machado, CA, additional, Nobre, F, additional, Nogueira, AR, additional, Mion Júnior, D, additional, Kaiser, S, additional, Forjaz, CLM, additional, Almeida, FA, additional, Martim, JFV, additional, Sass, N, additional, Drager, LF, additional, Muxfeldt, E, additional, Bodanese, LC, additional, Feitosa, AD, additional, Malta, D, additional, Fuchs, S, additional, Magalhães, ME, additional, Oigman, W, additional, Gomes, OM, additional, Pierin, AMG, additional, Feitosa, GS, additional, Bortolotto, MRFL, additional, Magalhães, LBNC, additional, Silva, ACS, additional, Ribeiro, JM, additional, Borelli, FAO, additional, Gus, M, additional, Passarelli Júnior, O, additional, Toledo, JY, additional, Salles, GF, additional, Martins, LC, additional, Jardim, TSV, additional, Guimarães, ICB, additional, Antonello, IC, additional, Lima Júnior, E, additional, Matsudo, V, additional, Silva, GV, additional, Costa, LS, additional, Alessi, A, additional, Scala, LCN, additional, Coelho, EB, additional, Souza, D, additional, Lopes, HF, additional, Gowdak, MMG, additional, Cordeiro Júnior, AC, additional, Torloni, MR, additional, Klein, MRST, additional, Nogueira, PK, additional, Lotaif, LAD, additional, Rosito, GBA, additional, and Moreno Júnior, H, additional

Published
2016
Full Text
View/download PDF

17. Precision assessment of a hypertension prevalence survey.

Author

Gianini RJ, Caneto NF, Junqueira NM, Rodrigues LG, Parri BZ, and Rodrigues CIS

Subjects
Humans, Prevalence, Adult, Male, Middle Aged, Female, Aged, Adolescent, Young Adult, Risk Factors, Brazil epidemiology, Hypertension epidemiology, Hypertension diagnosis, Health Surveys
Abstract

Background: Population surveys are crucial for public policy planning and provide valuable representative data. In the health sector studies to identify and assess the prevalence of Arterial Hypertension (AH), a chronic non-communicable disease (NCD), along with its associated risk factors have been conducted., Objectives: This study aims to assess the effectiveness of a population health survey in estimating the prevalence of arterial hypertension (AH) in the Sorocaba municipality between August 2021 and June 2023., Methods: The analyzed performance indicator is the precision (design effect - deff) of AH prevalence in adults (≥ 18 years) and their exposure to primary risk factors. The total sample included 1,080 individuals from the urban area, deemed sufficient to estimate a deff of 1.5. This cluster-based study utilized census sectors as clusters, with data collected through household interviews, standardized questionnaires, and measurements of blood pressure and biometric parameters. The deff calculation formula used was weighted variance / raw variance. The Research Ethics Committee approved this study, with registration CAAE 30538520-1-0000-5373., Results: The deff values ranged from 0.44 for chronic obstructive pulmonary disease to 1.63 for asthma, with a deff of 1.00 for AH prevalence., Conclusion: The study demonstrated good precision in its results, with high receptivity and cooperation from participants. The cost-effectiveness of the research deemed appropriate. The technique of selecting households within clusters (census sectors) based on detailed mapping and demographic data from the Instituto Brasileiro de Geografia e Estatística (IBGE) proved to be practical and efficient, suitable for replication in other municipalities and for studying other NCDs., (© 2024. The Author(s).)

Published
2024
Full Text
View/download PDF

18. Dialysis parameters associated with SARS-CoV-2 infection and prognosis in end-stage kidney disease.

Author

Bezerra R, Feitosa ADM, Silvestre OM, Fernandes-Silva MM, Amazonas RB, Teles F, Rodrigues CIS, Lima-Filho JL, Sposito AC, and Nadruz W Jr

Subjects
Humans, Female, Middle Aged, Male, Retrospective Studies, Prognosis, Aged, Brazil epidemiology, Adult, Hospitalization statistics & numerical data, Blood Pressure, COVID-19 complications, COVID-19 mortality, COVID-19 epidemiology, COVID-19 therapy, Kidney Failure, Chronic therapy, Kidney Failure, Chronic complications, Kidney Failure, Chronic mortality, Kidney Failure, Chronic epidemiology, Renal Dialysis statistics & numerical data, SARS-CoV-2
Abstract

Background: The Covid-19 pandemic has affected patients with end-stage kidney disease (ESKD). Whether dialysis parameters have a prognostic value in ESKD patients with Covid-19 remains unclear., Materials and Methods: We retrospectively evaluated clinical characteristics, blood pressure (BP) and dialysis parameters in ESKD patients undergoing maintenance outpatient hemodialysis, with (Covid-ESKD) and without (No-Covid-ESKD) Covid-19, at four Brazilian hemodialysis facilities. The Covid-ESKD ( n  = 107; 54% females; 60.8 ± 17.7 years) and No-Covid-ESKD ( n  = 107; 62% females; 58.4 ± 14.6 years) groups were matched by calendar time. The average BP and dialysis parameters were calculated during the pre-infection, acute infection, and post-infection periods. The main outcomes were Covid-19 hospitalization and all-cause mortality., Results: Covid-ESKD patients had greater intradialytic and postdialysis systolic BP and lower predialysis weight, postdialysis weight, ultrafiltration rate, and interdialytic weight gain during acute-illness compared to 1-week-before-illness, while these changes were not observed in No-Covid-ESKD patients. After 286 days of follow-up (range, 276-591), there were 18 Covid-19-related hospitalizations and 28 deaths among Covid-ESKD patients. Multivariable logistic regression analysis showed that increases in predialysis systolic BP from 1-week-before-illness to acute-illness (OR, 95%CI = 1.06, 1.02-1.10; p  = .004) and Covid-19 vaccination (OR, 95%CI = 0.16, 0.04-0.69; p  = .014) were associated with hospitalization in Covid-ESKD patients. Multivariable Cox-regression analysis showed that Covid-19-related hospitalization (HR, 95%CI = 5.17, 2.07-12.96; p  < .001) and age (HR, 95%CI = 1.05, 1.01-1.08; p  = .008) were independent predictors of all-cause mortality in Covid-ESKD patients., Conclusion: Acute Covid-19 illness is associated with variations in dialysis parameters of volume status in patients with ESKD. Furthermore, increases in predialysis BP during acute Covid-19 illness are associated with an adverse prognosis in Covid-ESKD patients.

Published
2024
Full Text
View/download PDF

19. Brazilian Guidelines for In-office and Out-of-office Blood Pressure Measurement - 2023.

Author

Feitosa ADM, Barroso WKS, Mion Junior D, Nobre F, Mota-Gomes MA, Jardim PCBV, Amodeo C, Oliveira AC, Alessi A, Sousa ALL, Brandão AA, Pio-Abreu A, Sposito AC, Pierin AMG, Paiva AMG, Spinelli ACS, Machado CA, Poli-de-Figueiredo CE, Rodrigues CIS, Forjaz CLM, Sampaio DPS, Barbosa ECD, Freitas EV, Cestario EDES, Muxfeldt ES, Lima Júnior E, Campana EMG, Feitosa FGAM, Consolim-Colombo FM, Almeida FA, Silva GVD, Moreno Júnior H, Finimundi HC, Guimarães ICB, Gemelli JR, Barreto-Filho JAS, Vilela-Martin JF, Ribeiro JM, Yugar-Toledo JC, Magalhães LBNC, Drager LF, Bortolotto LA, Alves MAM, Malachias MVB, Neves MFT, Santos MC, Dinamarco N, Moreira Filho O, Passarelli Júnior O, Vitorino PVO, Miranda RD, Bezerra R, Pedrosa RP, Paula RB, Okawa RTP, Póvoa RMDS, Fuchs SC, Lima SG, Inuzuka S, Ferreira-Filho SR, Fillho SHP, Jardim TSV, Guimarães Neto VDS, Koch VHK, Gusmão WDP, Oigman W, and Nadruz Junior W

Subjects
Humans, Brazil, Office Visits, Blood Pressure physiology, Female, Hypertension diagnosis, Blood Pressure Determination standards, Blood Pressure Determination methods, Blood Pressure Monitoring, Ambulatory standards, Blood Pressure Monitoring, Ambulatory methods
Published
2024
Full Text
View/download PDF

21. Arterial hypertension in kidney transplantation: huge importance, but few answers.

Author

Rebelo RNS and Rodrigues CIS

Subjects
Humans, Blood Pressure Monitoring, Ambulatory methods, Blood Pressure, Antihypertensive Agents therapeutic use, Kidney Transplantation, Hypertension, White Coat Hypertension drug therapy
Abstract

Arterial hypertension (AH) after renal transplantation (RTX) is correlated with worse cardiovascular and renal outcomes, with loss of renal function, decreased graft survival and higher mortality. RTX recipients have discrepant blood pressure (BP) values when measured in the office or by systematic methodologies, such as Ambulatory Blood Pressure Monitoring (ABPM), with significant prevalence of no nocturnal dipping or nocturnal hypertension, white coat hypertension and masked hypertension. The aim of the present study was to review the issue of hypertension in RTX, addressing its multifactorial pathophysiology and demonstrating the importance of ABPM as a tool for monitoring BP in these patients. Treatment is based on lifestyle changes and antihypertensive drugs, with calcium channel blockers considered first-line treatment. The best blood pressure target and treatment with more favorable outcomes in RTX are yet to be determined, through well-conducted scientific studies, that is, in terms of AH in RTX, we currently have more questions to answer than answers to give.

Published
2023
Full Text
View/download PDF

22. Translation, cross-cultural adaptation and validation of the EPOCH-RRT questionnaire "Empowering Patients On Choices For Renal Replacement Therapy" for the Brazilian context.

Author

Rodrigues LAS, Almeida FA, and Rodrigues CIS

Subjects
Humans, Brazil, Renal Replacement Therapy, Surveys and Questionnaires, Translations, Power, Psychological, Cross-Cultural Comparison, Renal Insufficiency, Chronic therapy
Abstract

Introduction: Chronic kidney disease (CKD) is a global public health problem. In Brazil, the incidence and prevalence rates of dialysis CKD progressively increase, but the transition process is a challenge for patients and caregivers in coping with the disease. Dialysis urgency, lack of planned access or prior knowledge of treatment is a reality for most. Guidelines recommend that treatment options should include the conscious preference of a fully informed patient. However, pre-dialysis educational information is an exception, leading to a large number of unplanned initial dialysis. The original study "Empowering Patients on Choices for Renal Replacement Therapy" (EPOCH-RRT) aimed to identify patient priorities and gaps in shared decision-making about dialysis, using structured interviews with questions about demographics, clinical history and patients' perception of their health. The goal of this study was to carry out the translation, cross-cultural adaptation and validation of the questionnaires used in the EPOCH-RRT Study for the Brazilian context., Method: This is a methodological study that consisted of the initial translation, synthesis of the translations, back translation, review by a committee of experts, pre-test and evaluation of the psychometric properties of the instrument. All ethical precepts were followed., Results: The questionnaires were translated, adapted and validated for the Brazilian context. Additionally, it was applied to 84 chronic renal patients on hemodialysis, peritoneal dialysis and outpatients., Discussion: There is a lack of an educational-therapeutic approach aimed at patients with CKD, and the EPOCH-RRT questionnaire can be a tool for Brazilian dialysis services to change this paradigm.

Published
2023
Full Text
View/download PDF

24. The Brazilian Society of Nephrology Code of Conduct: a bioethical analysis.

Author

Ferraz FHRP and Rodrigues CIS

Subjects
Beneficence, Brazil, Humans, Nephrology
Abstract

Introduction: Professional deontology can be defined as a set of principles, values and rules of conduct to be applied in the exercise of functions and inherent to a given profession. Nephrology was one of the medical specialties most affected by the mismatch between the accelerated technological development and the ethical dilemmas resulting from it. Recently, the Brazilian Society of Nephrology (SBN) edited its code of conduct, which until then did not exist., Method: Qualitative study with content analysis of the chapters and articles of the SBN Code of Conduct, from the perspective of principlism bioethics., Results: The four moral principles of beneficence, non-maleficence, autonomy and justice were found asymmetrically throughout the document, with beneficence predominating over the others., Discussion: The SBN Code of Conduct predominantly expresses the ethical duties that an associate must comply with, but also restrictions on malfeasance, autonomy and justice, anchoring decision-making by managers and including the distribution of possible punishments. It is an unfinished document; therefore, it must be periodically revised, as expected, due to the rapid technological changes, as well as the need for constructive moderation in the relations of nephrologists with each other and, between them, with the Industry, as well as all the ethical consequences arising from these factors.

Published
2022
Full Text
View/download PDF

25. Death and End of Life: Perceptions Throughout The Career About Death, Palliative Care, and Educational Process.

Author

Corradi MLG, Duim E, and Rodrigues CIS

Subjects
Cross-Sectional Studies, Curriculum, Death, Humans, Perception, Palliative Care, Terminal Care
Abstract

Purpose: To evaluate the perception of attending physicians, medical residents, and undergraduate medical students about death and dying, the end of life (EoL), and palliative care (PC) during training and clinical practice, highlighting knowledge gaps, and the changes needed in medical school curricula., Method: Cross-sectional study of 12 attending physicians, residents, and undergraduate medical students randomly selected from a single teaching hospital in São Paulo, Brazil, 2018. Semi-structured interviews were conducted, transcripts were coded in depth, and categorizing analysis was carried out., Results: Three topical categories were recognized: Negative feelings about death and the EoL, importance of PC, and gaps in curricular structure hindering preparedness for PC and EoL communication. Besides differing perspectives depending on their years of experience, all participants strongly endorsed that the current medical school curriculum does not train and support physicians to handle EoL and PC., Conclusions: Medical education plays a fundamental role in the development of knowledge and skills on death, dying, and PC. Such practices should extend throughout the course and be continuously improved after graduates move to clinical practice.

Published
2021
Full Text
View/download PDF

26. A review of Covid-19 and acute kidney injury: from pathophysiology to clinical results.

Author

Pecly IMD, Azevedo RB, Muxfeldt ES, Botelho BG, Albuquerque GG, Diniz PHP, Silva R, and Rodrigues CIS

Subjects
Humans, Proteinuria, Renal Replacement Therapy, SARS-CoV-2, Acute Kidney Injury therapy, COVID-19
Abstract

Acute kidney injury (AKI) in hospitalized patients with COVID-19 is associated with higher mortality and a worse prognosis. Nevertheless, most patients with COVID-19 have mild symptoms, and about 5% can develop more severe symptoms and involve hypovolemia and multiple organ dysfunction syndrome. In a pathophysiological perspective, severe SARS-CoV-2 infection is characterized by numerous dependent pathways triggered by hypercytokinemia, especially IL-6 and TNF-alpha, leading to systemic inflammation, hypercoagulability, and multiple organ dysfunction. Systemic endotheliitis and direct viral tropism to proximal renal tubular cells and podocytes are important pathophysiological mechanisms leading to kidney injury in patients with more critical infection, with a clinical presentation ranging from proteinuria and/or glomerular hematuria to fulminant AKI requiring renal replacement therapies. Glomerulonephritis, rhabdomyolysis, and nephrotoxic drugs are also associated with kidney damage in patients with COVID-19. Thus, AKI and proteinuria are independent risk factors for mortality in patients with SARS-CoV-2 infection. We provide a comprehensive review of the literature emphasizing the impact of acute kidney involvement in the evolutive prognosis and mortality of patients with COVID-19.

Published
2021
Full Text
View/download PDF

27. COVID-19 and chronic kidney disease: a comprehensive review.

Author

Pecly IMD, Azevedo RB, Muxfeldt ES, Botelho BG, Albuquerque GG, Diniz PHP, Silva R, and Rodrigues CIS

Subjects
Humans, Pandemics, Renal Dialysis, SARS-CoV-2, COVID-19, Renal Insufficiency, Chronic complications, Renal Insufficiency, Chronic epidemiology, Renal Insufficiency, Chronic therapy
Abstract

Kidney impairment in hospitalized patients with SARS-CoV-2 infection is associated with increased in-hospital mortality and worse clinical evolution, raising concerns towards patients with chronic kidney disease (CKD). From a pathophysiological perspective, COVID-19 is characterized by an overproduction of inflammatory cytokines (IL-6, TNF-alpha), causing systemic inflammation and hypercoagulability, and multiple organ dysfunction syndrome. Emerging data postulate that CKD under conservative treatment or renal replacement therapy (RRT) is an important risk factor for disease severity and higher in-hospital mortality amongst patients with COVID-19. Regarding RAAS blockers therapy during the pandemic, the initial assumption of a potential increase and deleterious impact in infectivity, disease severity, and mortality was not evidenced in medical literature. Moreover, the challenge of implementing social distancing in patients requiring dialysis during the pandemic prompted national and international societies to publish recommendations regarding the adoption of safety measures to reduce transmission risk and optimize dialysis treatment during the COVID-19 pandemic. Current data convey that kidney transplant recipients are more vulnerable to more severe infection. Thus, we provide a comprehensive review of the clinical outcomes and prognosis of patients with CKD under conservative treatment and dialysis, and kidney transplant recipients and COVID-19 infection.

Published
2021
Full Text
View/download PDF

28. Resistant hypertension: Prevalence and profile of patients followed in a university ambulatory.

Author

Moura AF, Moura-Neto JA, Rodrigues CIS, Miranda MO, Carvalho TC, Paschoalin Carvalho NP, Souza E, Moura-Jr JA, and Cruz CMS

Abstract

Background: Hypertension affects about 36 million Brazilians. It is estimated that 10%-20% of these have resistant hypertension. These patients are at an increased risk of early target organ damage, as well as cardiovascular and renal events., Objective: To estimate the prevalence of resistant hypertension in a specialized outpatient clinic, to describe the sociodemographic and clinical characteristics of these patients, and to identify possible factors associated with resistant hypertension., Methods: Data collection from medical records of hypertensive patients treated using oral antihypertensive drugs in optimized doses at a specialized university clinic from March 2014 to December 2014, after ethical approval statement. All patients were using appropriate antihypertensive drugs in optimized doses and assisted at a teaching-assistance clinic of internal medicine of the Bahiana School of Medicine and Public Health in Brazil., Results: A total of 104 patients were enrolled and 31.7% (n = 33) had criteria for resistant hypertension. Of the total participants, 75.7% were female and 54.8% were black or brown. The average age was 61.7 years (SD ± 10.1). In the resistant hypertension group, 63.6% had diabetes, compared to 32.4% in the hypertension group. Among resistant hypertensive patients, 51.5% had dyslipidemia. Regarding drug treatment, 75.8% of the resistant hypertension group and 51.4% of the hypertension group used statins. Among patients with resistant hypertension, 90.9% used angiotensin II receptor blockers and 66.7%, dihydropyridine calcium channel blockers. In the resistant hypertension group, 75.8% used beta-blockers, against 25.4% in the hypertension group., Conclusion: The prevalence of hypertension was higher than that described in the global literature, which may be associated with the high percentage of black and brown ("pardos") patients in the population studied, and also because the study was performed in a specialized outpatient clinic., Competing Interests: Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (© The Author(s) 2021.)

Published
2021
Full Text
View/download PDF

29. Aerobic growth physiology of Saccharomyces cerevisiae on sucrose is strain-dependent.

Author

Rodrigues CIS, Wahl A, and Gombert AK

Subjects
Aerobiosis, Bioreactors, Biotechnology, Fructose metabolism, Glucose metabolism, Phenotype, Saccharomyces cerevisiae classification, Saccharomyces cerevisiae Proteins genetics, Saccharomyces cerevisiae Proteins metabolism, Saccharomyces cerevisiae growth & development, Saccharomyces cerevisiae physiology, Sucrose metabolism
Abstract

Present knowledge on the quantitative aerobic physiology of the yeast Saccharomyces cerevisiae during growth on sucrose as sole carbon and energy source is limited to either adapted cells or to the model laboratory strain CEN.PK113-7D. To broaden our understanding of this matter and open novel opportunities for sucrose-based biotechnological processes, we characterized three strains, with distinct backgrounds, during aerobic batch bioreactor cultivations. Our results reveal that sucrose metabolism in S. cerevisiae is a strain-specific trait. Each strain displayed distinct extracellular hexose concentrations and invertase activity profiles. Especially, the inferior maximum specific growth rate (0.21 h-1) of the CEN.PK113-7D strain, with respect to that of strains UFMG-CM-Y259 (0.37 h-1) and JP1 (0.32 h-1), could be associated to its low invertase activity (0.04-0.09 U/mgDM). Moreover, comparative experiments with glucose or fructose alone, or in combination, suggest mixed mechanisms of sucrose utilization by the industrial strain JP1, and points out the remarkable ability of the wild isolate UFMG-CM-259 to grow faster on sucrose than on glucose in a well-controlled cultivation system. This work hints to a series of metabolic traits that can be exploited to increase sucrose catabolic rates and bioprocess efficiency., (© The Author(s) 2021. Published by Oxford University Press on behalf of FEMS.)

Published
2021
Full Text
View/download PDF

30. Brazilian Guidelines of Hypertension - 2020.

Author

Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brandão AA, Feitosa ADM, Machado CA, Poli-de-Figueiredo CE, Amodeo C, Mion Júnior D, Barbosa ECD, Nobre F, Guimarães ICB, Vilela-Martin JF, Yugar-Toledo JC, Magalhães MEC, Neves MFT, Jardim PCBV, Miranda RD, Póvoa RMDS, Fuchs SC, Alessi A, Lucena AJG, Avezum A, Sousa ALL, Pio-Abreu A, Sposito AC, Pierin AMG, Paiva AMG, Spinelli ACS, Nogueira ADR, Dinamarco N, Eibel B, Forjaz CLM, Zanini CRO, Souza CB, Souza DDSM, Nilson EAF, Costa EFA, Freitas EV, Duarte EDR, Muxfeldt ES, Lima Júnior E, Campana EMG, Cesarino EJ, Marques F, Argenta F, Consolim-Colombo FM, Baptista FS, Almeida FA, Borelli FAO, Fuchs FD, Plavnik FL, Salles GF, Feitosa GS, Silva GVD, Guerra GM, Moreno Júnior H, Finimundi HC, Back IC, Oliveira Filho JB, Gemelli JR, Mill JG, Ribeiro JM, Lotaif LAD, Costa LSD, Magalhães LBNC, Drager LF, Martin LC, Scala LCN, Almeida MQ, Gowdak MMG, Klein MRST, Malachias MVB, Kuschnir MCC, Pinheiro ME, Borba MHE, Moreira Filho O, Passarelli Júnior O, Coelho OR, Vitorino PVO, Ribeiro Junior RM, Esporcatte R, Franco R, Pedrosa R, Mulinari RA, Paula RB, Okawa RTP, Rosa RF, Amaral SLD, Ferreira-Filho SR, Kaiser SE, Jardim TSV, Guimarães V, Koch VH, Oigman W, and Nadruz W

Subjects
Brazil, Humans, Hypertension diagnosis, Hypertension prevention & control
Published
2021
Full Text
View/download PDF

31. Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection.

Author

Rodrigues CIS

Subjects
Brazil, COVID-19, Humans, Nephrology, Pandemics, SARS-CoV-2, Withholding Treatment, Angiotensin II Type 1 Receptor Blockers therapeutic use, Angiotensin-Converting Enzyme Inhibitors therapeutic use, Betacoronavirus, Coronavirus Infections epidemiology, Hypertension drug therapy, Pneumonia, Viral epidemiology
Abstract

This position statement of the Department of Hypertension of the Brazilian Society of Nephrology (SBN) addresses the controversy surrounding the use or suspension/replacement of the renin-angiotensin-aldosterone system blockers (particularly inhibitors of the angiotensin-converting enzyme or angiotensin II AT1 receptor blockers) prophylactically in individuals using these drugs, due to the possibility of allegedly worsening the prognosis of hypertensive patients infected with SARS-CoV-2. The SBN Hypertension Department recommends individualizing treatment and maintaining these medications until better scientific evidence is available.

Published
2020
Full Text
View/download PDF

32. Brazilian Position Statement on Resistant Hypertension - 2020.

Author

Yugar-Toledo JC, Moreno Júnior H, Gus M, Rosito GBA, Scala LCN, Muxfeldt ES, Alessi A, Brandão AA, Moreira Filho O, Feitosa ADM, Passarelli Júnior O, Souza DDSM, Amodeo C, Barroso WKS, Gomes MAM, Paiva AMG, Barbosa ECD, Miranda RD, Vilela-Martin JF, Nadruz Júnior W, Rodrigues CIS, Drager LF, Bortolotto LA, Consolim-Colombo FM, Sousa MG, Borelli FAO, Kaiser SE, Salles GF, Azevedo MF, Magalhães LBNC, Póvoa RMDS, Malachias MVB, Nogueira ADR, Jardim PCBV, and Jardim TSV

Subjects
Blood Pressure, Brazil, Humans, Hypertension
Published
2020
Full Text
View/download PDF

33. Risk stratification for complications of laparoscopic cholecystectomy based on associations with sociodemographic and clinical variables in a public hospital.

Author

de Siqueira Corradi MB, D Ávila R, Duim E, and Rodrigues CIS

Subjects
Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Brazil epidemiology, Cross-Sectional Studies, Diabetes Mellitus epidemiology, Emergencies, Female, Hospitals, Public, Humans, Intraoperative Complications, Male, Middle Aged, Postoperative Complications, Retrospective Studies, Risk Factors, Sex Factors, Young Adult, Cholecystectomy, Laparoscopic adverse effects, Risk Assessment
Abstract

Background: Cholelithiasis is the most common disease of the biliary tract. We aimed to associate complications resulting from laparoscopic cholecystectomy with patients' sociodemographic and clinical data, stratifying risk based on this association., Methods: We retrospectively reviewed the medical records of 2520 patients undergoing laparoscopic cholecystectomy from January 2013 to March 2017 at our institution. Sociodemographic, clinical, and surgical complication data were collected. Unadjusted and adjusted logistic regression models were used to determine independent factors associated with the outcomes of interest. Based on the results, we proposed a risk stratification model, a treatment flowchart, and a severity score., Results: Mean age was 48.9 years; 83.53% were female. Intraoperative complications occurred in 206 (8.17%) patients, and postoperative complications in 54 (2.14%). Male sex, older age, diabetes, multiple previous operations, and urgent surgery (odds ratio = 23.77) were significantly associated with surgical complications in both unadjusted and adjusted models., Conclusions: We could propose a flowchart based on our risk stratification model and develop a severity score based on the association between complications of laparoscopic cholecystectomy and sociodemographic/clinical data., (Copyright © 2019 Elsevier Inc. All rights reserved.)

Published
2020
Full Text
View/download PDF

35. Nephrologists and patients: between vulnerability and equity.

Author

Ferraz FHRP, Rodrigues CIS, Gatto GC, and Sá NM

Subjects
Humans, Medical Tourism, Physician-Patient Relations, Vulnerable Populations, Healthcare Disparities, Kidney Transplantation ethics, Kidney Transplantation legislation & jurisprudence, Nephrologists, Renal Insufficiency, Chronic therapy
Published
2019
Full Text
View/download PDF

36. Assessment of feedback for the teaching of nursing practice.

Author

Montes LG, Rodrigues CIS, and Azevedo GR

Subjects
Adult, Female, Focus Groups methods, Humans, Nursing Care methods, Psychometrics instrumentation, Psychometrics methods, Qualitative Research, Surveys and Questionnaires, Feedback, Nursing Care standards
Abstract

Objective: to analyze the self-reported knowledge of professors in the use of feedback in the teaching of nursing practice; train professors to use this process; and evaluate the results of this training., Method: a qualitative study of research-action type. The focus group technique was used with seven collaborators of a nursing technical school. For content analysis, the Bardin framework was used and, for intervention, the Problematization Methodology supported by Pendleton’s Rules., Results: most present in their curricula training to teach. It is pointed out that feedback is a simple and essential assessment tool, although universal discourse does not express the exact dimension of feedback potentialities. The intervention was effective to solidify feedback., Final Consideration: this study shows that feedback should be disseminated and consolidated among the teaching staff of nursing technical education [corrected].

Published
2019
Full Text
View/download PDF

38. Resistant and refractory hypertension: two sides of the same disease?

Author

Muxfeldt ES, Chedier B, and Rodrigues CIS

Subjects
Alcohol Drinking adverse effects, Antihypertensive Agents pharmacology, Blood Pressure drug effects, Blood Pressure Monitoring, Ambulatory, Complementary Therapies, Diet, Sodium-Restricted, Dietary Approaches To Stop Hypertension, Diuretics pharmacology, Exercise, Humans, Hypertension diagnosis, Hypertension physiopathology, Phenotype, Prevalence, Smoking adverse effects, Sympatholytics therapeutic use, Drug Resistance, Hypertension drug therapy, Hypertension epidemiology
Abstract

Refractory hypertension (RfH) is an extreme phenotype of resistant hypertension (RH), being considered an uncontrolled blood pressure besides the use of 5 or more antihypertensive medications, including a long-acting thiazide diuretic and a mineralocorticoid antagonist. RH is common, with 10-20% of the general hypertensives, and its associated with renin angiotensin aldosterone system hyperactivity and excess fluid retention. RfH comprises 5-8% of the RH and seems to be influenced by increased sympathetic activity. RH patients are older and more obese than general hypertensives. It is strongly associated with diabetes, obstructive sleep apnea, and hyperaldosteronism status. RfH is more frequent in women, younger patients and Afro-americans compared to RFs. Both are associated with increased albuminuria, left ventricular hypertrophy, chronic kidney diseases, stroke, and cardiovascular diseases. The magnitude of the white-coat effect seems to be higher among RH patients. Intensification of diuretic therapy is indicated in RH, while in RfH, therapy failure imposes new treatment alternatives such as the use of sympatholytic therapies. In conclusion, both RH and RfH constitute challenges in clinical practice and should be addressed as distinct clinical entities by trained professionals who are capable to identify comorbidities and provide specific, diversified, and individualized treatment.

Published
2019
Full Text
View/download PDF

39. Differences and inequalities in relation to access to renal replacement therapy in the BRICS countries.

Author

Ferraz FHRP, Rodrigues CIS, Gatto GC, and Sá NM

Subjects
Bioethical Issues, Cross-Sectional Studies, Developing Countries, Humans, International Cooperation, Kidney Failure, Chronic economics, Kidney Transplantation economics, Kidney Transplantation methods, Public Health, Renal Replacement Therapy economics, Health Services Accessibility, Healthcare Disparities economics, Kidney Failure, Chronic therapy, Renal Replacement Therapy methods
Abstract

End-stage renal disease (ESRD) is an important public health problem, especially in developing countries due to the high level of economic resources needed to maintain patients in the different programs that make up renal replacement therapy (RRT). To analyze the differences and inequalities involved in access to RRT in the BRICS countries (Brazil, Russian Federation, India, China and South Africa). This is an applied, descriptive, cross-sectional, quantitative and qualitative study, with documentary analysis and a literature review. The sources of data were from national censuses and scientific publications regarding access to RRT in the BRICS countries. There is unequal access to RRT in all the BRICS countries, as well as the absence of information regarding dialysis and transplants (India), the absence of effective legislation to inhibit the trafficking of organs (India and South Africa) and the use of deceased prisoners as donors for renal transplants (China). The construction of mechanisms to promote the sharing of benefits and solidarity in the field of international cooperation in the area of renal health involves the recognition of bioethical issues related to access to RRT in the BRICS countries.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results